株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心調律管理(CRM)装置の世界市場 - 市場規模、シェア、見通し、市場機会の分析 2018年~2026年

Cardiac Rhythm Management Devices Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

発行 Coherent Market Insights 商品コード 769541
出版日 ページ情報 英文 155 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.53円で換算しております。
Back to Top
心調律管理(CRM)装置の世界市場 - 市場規模、シェア、見通し、市場機会の分析 2018年~2026年 Cardiac Rhythm Management Devices Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
出版日: 2018年12月14日 ページ情報: 英文 155 Pages
概要

心調律管理(CRM)は不整脈(心調律障害)または心房細動(AF)の治療法です。不整脈は動悸やめまい、突然の心停止など患者にさまざまな問題を引き起こす可能性があります。ペースメーカー、心臓再同期療法(CRT)装置、植え込み型心臓除細動器(ICD)などの心調律管理(CRM)装置は、信頼性および耐久性が急速に向上しています。

当レポートでは、世界の心調律管理(CRM)装置市場を調査し、市場の概要、製品タイプ・エンドユーザー・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場概要

  • レポート概要
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • 市場スニペット:製品タイプ別
    • 市場スニペット:エンドユーザー別
    • 市場スニペット:地域別
  • コヒーレントオポチュニティマップ(COM)

第3章 市場力学、規制、市場動向の分析

  • 市場力学
    • 成長要因
    • 阻害要因
    • 市場機会
  • 影響分析
  • 市場動向
  • 新製品の承認/発売
  • 技術の進歩
  • 規制の状況
  • 償還シナリオ
  • 疫学分析
  • PEST分析
  • ファイブフォース分析

第4章 世界の心調律管理(CRM)装置市場:製品タイプ別

  • イントロダクション
  • 心臓再同期療法(CRT)装置
  • 除細動器
  • ペースメーカー

第5章 世界の心調律管理(CRM)装置市場:エンドユーザー別

  • イントロダクション
  • 病院
  • 在宅介護
  • 外来治療

第6章 世界の心調律管理(CRM)装置市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • アフリカ
  • 中東

第7章 競争環境

  • ヒートマップ解析
  • 企業プロファイル
    • Medtronic plc.
    • Abbott Laboratories
    • Abiomed
    • Boston Scientific Corporation
    • Biotronik Se Co Kg
    • Koninklijke Philips N.V.
    • LivaNova Plc.
    • Cardiac Science Corporation
    • Schiller Ag
    • Zoll Medical Corporation

第8章 アナリストの見解

第9章 セクション

目次
  • Cardiac rhythm management (CRM) is the treatment of arrhythmias (heart rhythm disorders) or atrial fibrillation (AF). Arrhythmias can cause a range of problems for patients, from palpitations and dizzy spells to sudden cardiac arrest. Cardiac rhythm management devices such as pacemakers, cardiac resynchronization therapy (CRT) devices and implantable cardiac defibrillators (ICDs) continue to evolve rapidly in reliability and lifespan. Most CRM devices are implanted under the skin, with one to three leads threaded down a vein to connect to the heart.

Market Dynamics

  • Increasing incidences of heart failure and arrhythmia have fuelled rapid advancements in cardiac rhythm management (CRM) technologies eventually increasing the demand for CRM devices. According to the study published in 2016, by the Journal of the Formosan Medical Association, around 72 million people are estimated to suffer from atrial fibrillation in Asia by 2050, which is expected to be more than double the combined numbers of patients from the U.S. and Europe.
  • However, factors such as chances of infections associated with installation of pacemakers in cardiac patients can hamper the cardiac rhythm management devices market growth. Pacemaker surgery can also led to various complications such as bleeding, bruising or swelling at the of area of pacemaker implantation leading to blood vessel or nerve damage, which in turn can reduce adoption of cardiac implants in patients.

Key features of the study:

  • This report provides in-depth analysis of the cardiac rhythm management devices market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 - 2026, considering 2017, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global cardiac rhythm management devices market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Medtronic plc, Abbott Laboratories, Abiomed, Boston Scientific Corporation, Biotronik Se Co Kg, Koninklijke Philips N.V., LivaNova Plc, Cardiac Science Corporation, Schiller Ag, and Zoll Medical Corporation
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global cardiac rhythm management devices market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for cardiac rhythm management devices market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Cardiac Rhythm Management Devices Market, By Product Type:
  • Cardiac Resynchronization Therapy Devices
    • Cardiac Resynchronization Therapy Defibrillators (CRT-D)
    • Cardiac Resynchronization Therapy Pacemakers (CRT-P)
  • Defibrillator
    • Implantable Cardioverter Defibrillators (ICDS)
    • External Defibrillators
  • Pacemakers
    • Single Chamber Pacemakers
    • Dual Chamber Pacemakers
    • Biventricular Pacemakers
  • Global Cardiac Rhythm Management Devices Market, By End User:
  • Hospital
  • Home Care Settings
  • Ambulatory Care Settings
  • Global Cardiac Rhythm Management Devices Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
    • By Product Type:
  • Cardiac Resynchronization Therapy Devices
  • Cardiac Resynchronization Therapy Defibrillators (CRT-D)
  • Cardiac Resynchronization Therapy Pacemakers (CRT-P)
  • Defibrillator
  • Implantable Cardioverter Defibrillators (ICDS)
  • External Defibrillators
  • Pacemakers
  • Single Chamber Pacemakers
  • Dual Chamber Pacemakers
  • Biventricular Pacemakers
    • By End User:
  • Hospital
  • Home Care Settings
  • Ambulatory Care Settings
  • Europe
    • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
    • By Product Type:
  • Cardiac Resynchronization Therapy Devices
  • Cardiac Resynchronization Therapy Defibrillators (CRT-D)
  • Cardiac Resynchronization Therapy Pacemakers (CRT-P)
  • Defibrillator
  • Implantable Cardioverter Defibrillators (ICDS)
  • External Defibrillators
  • Pacemakers
  • Single Chamber Pacemakers
  • Dual Chamber Pacemakers
  • Biventricular Pacemakers
    • By End User:
  • Hospital
  • Home Care Settings
  • Ambulatory Care Settings
  • Asia Pacific
    • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
    • By Product Type:
  • Cardiac Resynchronization Therapy Devices
  • Cardiac Resynchronization Therapy Defibrillators (CRT-D)
  • Cardiac Resynchronization Therapy Pacemakers (CRT-P)
  • Defibrillator
  • Implantable Cardioverter Defibrillators (ICDS)
  • External Defibrillators
  • Pacemakers
  • Single Chamber Pacemakers
  • Dual Chamber Pacemakers
  • Biventricular Pacemakers
    • By End User:
  • Hospital
  • Home Care Settings
  • Ambulatory Care Settings
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
    • By Product Type:
  • Cardiac Resynchronization Therapy Devices
  • Cardiac Resynchronization Therapy Defibrillators (CRT-D)
  • Cardiac Resynchronization Therapy Pacemakers (CRT-P)
  • Defibrillator
  • Implantable Cardioverter Defibrillators (ICDS)
  • External Defibrillators
  • Pacemakers
  • Single Chamber Pacemakers
  • Dual Chamber Pacemakers
  • Biventricular Pacemakers
    • By End User:
  • Hospital
  • Home Care Settings
  • Ambulatory Care Settings
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
    • By Product Type:
  • Cardiac Resynchronization Therapy Devices
  • Cardiac Resynchronization Therapy Defibrillators (CRT-D)
  • Cardiac Resynchronization Therapy Pacemakers (CRT-P)
  • Defibrillator
  • Implantable Cardioverter Defibrillators (ICDS)
  • External Defibrillators
  • Pacemakers
  • Single Chamber Pacemakers
  • Dual Chamber Pacemakers
  • Biventricular Pacemakers
    • By End User:
  • Hospital
  • Home Care Settings
  • Ambulatory Care Settings
  • Africa
    • By Country:
  • South Africa
  • Central Africa
  • North Africa
    • By Product Type:
  • Cardiac Resynchronization Therapy Devices
  • Cardiac Resynchronization Therapy Defibrillators (CRT-D)
  • Cardiac Resynchronization Therapy Pacemakers (CRT-P)
  • Defibrillator
  • Implantable Cardioverter Defibrillators (ICDS)
  • External Defibrillators
  • Pacemakers
  • Single Chamber Pacemakers
  • Dual Chamber Pacemakers
  • Biventricular Pacemakers
    • By End User:
  • Hospital
  • Home Care Settings
  • Ambulatory Care Settings
  • Company Profiles
  • Medtronic plc*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Abbott Laboratories
  • Abiomed
  • Boston Scientific Corporation
  • Biotronik Se Co Kg
  • Koninklijke Philips N.V.
  • LivaNova Plc
  • Cardiac Science Corporation
  • Schiller Ag
  • Zoll Medical Corporation

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • New Product Launches and Approvals
  • Technological Advancements
  • Regulatory Landscape
  • Reimbursement Scenario
    • North America
    • Europe
    • Asia Pacific
  • Epidemiology Analysis
  • PEST Analysis
  • Porter's Analysis

4. Global Cardiac Rhythm Management Devices Market, By Product Type, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Cardiac Resynchronization Therapy Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
    • Cardiac Resynchronization Therapy Defibrillators (CRT-D)
    • Cardiac Resynchronization Therapy Pacemakers (CRT-P)
  • Defibrillator
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
    • Implantable Cardioverter Defibrillators (ICDS)
    • External Defibrillators
  • Pacemakers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
    • Single Chamber Pacemakers
    • Dual Chamber Pacemakers
    • Biventricular Pacemakers

5. Global Cardiac Rhythm Management Devices Market, By End User, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Ambulatory Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

6. Global Cardiac Rhythm Management Devices Market, By Region, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2016 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Northern Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Medtronic plc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Abiomed
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Boston Scientific Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Biotronik Se Co Kg
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Koninklijke Philips N.V.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • LivaNova Plc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Cardiac Science Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Schiller Ag
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Zoll Medical Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

8. Analyst Views

9. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top